| CADM1 impairs the effect of miR-1246 on promoting cell cycle progression in chemo-resistant leukemia cells. | CADM1 impairs the effect of miR-1246 on promoting cell cycle progression in chemo-resistant leukemia cells.
Xie B, Zhao L, Zhang Z, Zhou C, Tian Y, Kang Y, Chen J, Wei H, Li L., Free PMC Article | 11/2/2023 |
| Cell adhesion molecule 1 expression in mycosis fungoides versus parapsoriasis versus inflammatory dermatosis: an immunohistochemical comparative study. | Cell adhesion molecule 1 expression in mycosis fungoides versus parapsoriasis versus inflammatory dermatosis: an immunohistochemical comparative study.
Neinaa YME, El-Maadawy IH, Atteia IA, Mohamed DAE. | 08/30/2023 |
| Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production. | Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production.
Wu X, Azizan EAB, Goodchild E, Garg S, Hagiyama M, Cabrera CP, Fernandes-Rosa FL, Boulkroun S, Kuan JL, Tiang Z, David A, Murakami M, Mein CA, Wozniak E, Zhao W, Marker A, Buss F, Saleeb RS, Salsbury J, Tezuka Y, Satoh F, Oki K, Udager AM, Cohen DL, Wachtel H, King PJ, Drake WM, Gurnell M, Ceral J, Ryska A, Mustangin M, Wong YP, Tan GC, Solar M, Reincke M, Rainey WE, Foo RS, Takaoka Y, Murray SA, Zennaro MC, Beuschlein F, Ito A, Brown MJ., Free PMC Article | 06/14/2023 |
| Interaction of the Hemagglutinin Stalk Region with Cell Adhesion Molecule (CADM) 1 and CADM2 Mediates the Spread between Neurons and Neuropathogenicity of Measles Virus with a Hyperfusogenic Fusion Protein. | Interaction of the Hemagglutinin Stalk Region with Cell Adhesion Molecule (CADM) 1 and CADM2 Mediates the Spread between Neurons and Neuropathogenicity of Measles Virus with a Hyperfusogenic Fusion Protein.
Takemoto R, Hirai Y, Watanabe S, Harada H, Suzuki T, Hashiguchi T, Yanagi Y, Shirogane Y., Free PMC Article | 06/2/2023 |
| Analysis of the key ligand receptor CADM1_CADM1 in the regulation of thyroid cancer based on scRNA-seq and bulk RNA-seq data. | Analysis of the key ligand receptor CADM1_CADM1 in the regulation of thyroid cancer based on scRNA-seq and bulk RNA-seq data.
He H, Cong S, Wang Y, Ji Q, Liu W, Qu N., Free PMC Article | 01/11/2023 |
| DNA hypermethylation of CADM1, PAX5, WT1, RARbeta, and PAX6 genes in oropharyngeal cancer associated with human papillomavirus. | DNA hypermethylation of CADM1, PAX5, WT1, RARβ, and PAX6 genes in oropharyngeal cancer associated with human papillomavirus.
Birknerová N, Kovaříková H, Baranová I, Přikrylová A, Laco J, Vošmiková H, Gajdošová B, Hodek M, Vošmik M, Palička V, Chmelařová M., Free PMC Article | 10/29/2022 |
| Evidence of islet CADM1-mediated immune cell interactions during human type 1 diabetes. | Evidence of islet CADM1-mediated immune cell interactions during human type 1 diabetes.
Sona C, Yeh YT, Patsalos A, Halasz L, Yan X, Kononenko NL, Nagy L, Poy MN., Free PMC Article | 04/30/2022 |
| Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis. | Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis.
Sun Z, Zhao L, Wang S, Wang H. | 04/9/2022 |
| The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11. | The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
Lafage-Pochitaloff M, Gerby B, Baccini V, Largeaud L, Fregona V, Prade N, Juvin PY, Jamrog L, Bories P, Hébrard S, Lagarde S, Mansat-De Mas V, Dovey OM, Yusa K, Vassiliou GS, Jansen JH, Tekath T, Rombaut D, Ameye G, Barin C, Bidet A, Boudjarane J, Collonge-Rame MA, Gervais C, Ittel A, Lefebvre C, Luquet I, Michaux L, Nadal N, Poirel HA, Radford-Weiss I, Ribourtout B, Richebourg S, Struski S, Terré C, Tigaud I, Penther D, Eclache V, Fontenay M, Broccardo C, Delabesse E., Free PMC Article | 04/9/2022 |
| miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1. | miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1.
Li C, Wang Y, Wang H, Wang B, Wang Y, Li N, Qin Y, Wang Y., Free PMC Article | 02/12/2022 |
| Differential Expression of CADM1 in Gastrointestinal Stromal Tumors of Different Sites and with Different Gene Abnormalities. | Differential Expression of CADM1 in Gastrointestinal Stromal Tumors of Different Sites and with Different Gene Abnormalities.
Yuan J, Kihara T, Kimura N, Hashikura Y, Ohkouchi M, Isozaki K, Takahashi T, Nishida T, Ito A, Hirota S., Free PMC Article | 01/8/2022 |
| MiR-423-5p aggravates lung adenocarcinoma via targeting CADM1. | MiR-423-5p aggravates lung adenocarcinoma via targeting CADM1.
Huang Y, Feng G., Free PMC Article | 11/22/2021 |
| Proximity proteomics identifies PAK4 as a component of Afadin-Nectin junctions. | Proximity proteomics identifies PAK4 as a component of Afadin-Nectin junctions.
Baskaran Y, Tay FP, Ng EYW, Swa CLF, Wee S, Gunaratne J, Manser E., Free PMC Article | 10/9/2021 |
| Expression of cell adhesion molecule 1 in human and murine endometrial glandular cells and its increase during the proliferative phase by estrogen and cell density. | Expression of cell adhesion molecule 1 in human and murine endometrial glandular cells and its increase during the proliferative phase by estrogen and cell density.
Kimura R, Otani T, Shiraishi N, Hagiyama M, Yoneshige A, Wada A, Kajiyama H, Takeuchi F, Mizuguchi N, Morishita K, Ito A. | 09/18/2021 |
| CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in cis. | CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in cis.
Shirogane Y, Takemoto R, Suzuki T, Kameda T, Nakashima K, Hashiguchi T, Yanagi Y., Free PMC Article | 08/28/2021 |
| Expression of TSLC1 in patients with HAM/TSP. | Expression of TSLC1 in patients with HAM/TSP.
Takenouchi N, Tanaka M, Sato T, Yao J, Fujisawa JI, Izumo S, Kubota R, Matsuura E. | 07/10/2021 |
| Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma. | Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma.
Nakahata S, Syahrul C, Nakatake A, Sakamoto K, Yoshihama M, Nishikata I, Ukai Y, Matsuura T, Kameda T, Shide K, Kubuki Y, Hidaka T, Kitanaka A, Ito A, Takemoto S, Nakano N, Saito M, Iwanaga M, Sagara Y, Mochida K, Amano M, Maeda K, Sueoka E, Okayama A, Utsunomiya A, Shimoda K, Watanabe T, Morishita K., Free PMC Article | 07/10/2021 |
| The Role of Cell Adhesion Molecule 1 (CADM1) in Cutaneous Malignancies. | The Role of Cell Adhesion Molecule 1 (CADM1) in Cutaneous Malignancies.
Sawada Y, Mashima E, Saito-Sasaki N, Nakamura M., Free PMC Article | 04/13/2021 |
| Cell Adhesion Molecule 1 Contributes to Cell Survival in Crowded Epithelial Monolayers. | Cell Adhesion Molecule 1 Contributes to Cell Survival in Crowded Epithelial Monolayers.
Hagiyama M, Kimura R, Yoneshige A, Inoue T, Otani T, Ito A., Free PMC Article | 03/27/2021 |
| The Role of CADM1 and MAL Promoter Methylation in Inflammation and Cervical Intraepithelial Neoplasia. | The Role of CADM1 and MAL Promoter Methylation in Inflammation and Cervical Intraepithelial Neoplasia.
Holubekova V, Mersakova S, Grendar M, Snahnicanova Z, Kudela E, Kalman M, Lasabova Z, Danko J, Zubor P. | 03/6/2021 |
| Prokaryotic Expression of the Immunoglobulin's Domains of CRTAM to Characterize a Monoclonal Antibody. | Prokaryotic Expression of the Immunoglobulin's Domains of CRTAM to Characterize a Monoclonal Antibody.
Barragan-Galvez JC, Gonzalez-Orozco M, Hernandez-Flores A, Maravillas-Montero JL, Chavez-Guerrero Y, Ortiz-Navarrete V. | 01/16/2021 |
| Identification of rare variants in CADM1 in patients with anorexia nervosa. | Identification of rare variants in CADM1 in patients with anorexia nervosa.
Lin Z, Lebrun N, Clarke J, Duriez P, Gorwood P, Ramoz N, Bienvenu T. | 12/26/2020 |
| Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia/lymphoma. | Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia/lymphoma.
Chilmi S, Nakahata S, Fauzi YR, Ichikawa T, Tani C, Suwanruengsri M, Yamaguchi R, Matsuura T, Kurosawa G, Morishita K. | 11/21/2020 |
| Nectin-like molecule 2, a necessary sexual maturation regulator, participates in congenital hypogonadotropic hypogonadism. | Nectin-like molecule 2, a necessary sexual maturation regulator, participates in congenital hypogonadotropic hypogonadism.
Tang R, Liu X, Peng Y, Ju W, Hao W, Peng X, Chen R. | 08/13/2020 |
| The findings suggest, for the first time, that the tumor microenvironment in acute lymphoblastic leukemia directly contribute to exhaustion of NK cell functions by the CRTAM/Necl-2 interaction, and that the potential regulatory role of exhausted-like NK cells may favor malignant progression at the expense of anti-tumor responses. | CRTAM(+) NK cells endowed with suppressor properties arise in leukemic bone marrow.
Ramírez-Ramírez D, Padilla-Castañeda S, Galán-Enríquez CS, Vadillo E, Prieto-Chávez JL, Jiménez-Hernández E, Vilchis-Ordóñez A, Sandoval A, Balandrán JC, Pérez-Tapia SM, Ortiz-Navarrete V, Pelayo R. | 05/9/2020 |